Medtronic (MDT) Stock Research, Analysis & News

Quick Analysis on Medtronic (MDT) Stock as of November 19, 2019

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Medtronic (MDT) Stock below)

Medtronic (MDT) Stock Profile Summary

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The companys Cardiac Rhythm Disease Management segment offers products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, including implantable cardioverter-defibrillators, cardiac resynchronization therapy devices, and cardiac pacemakers; AF products; diagnostics and monitoring devices; and patient management tools. Its Spinal segment provides medical devices and implants used in the treatment of the spine and the musculoskeletal system, such as thoracolumbar, cervical, and biologics products; and minimal access spinal technologies platform that facilitates spinal surgeries. Medtronics CardioVascular segment offers percutaneous coronary and peripheral vascular interventions; endovascular stent grafts; arrested heart surgery and beating heart surgery equipment; surgical ablations; and surgical heart and transcatheter heart valves. The companys Neuromodulation segment provides neurostimulators for chronic pain; implantable drug delivery and deep brain stimulation systems; and urology and gastroenterology devices. Its Diabetes segment offers integrated diabetes management solutions; professional CGM; carelink therapy management software; and blood glucose meters. The companys Surgical Technologies segment develops, manufactures, and markets products and therapies to treat diseases and conditions of the ear, nose, and throat, as well as certain neurological disorders; and image-guided surgery and intra-operative imaging systems that facilitate surgical planning during surgeries. Its Physio-Control segment offers external defibrillators, including manual defibrillator/monitors used by hospitals and emergency response personnel; and automated external defibrillators used in commercial and public settings for the treatment of sudden cardiac arrest. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.

Medtronic (MDT) Stock Key Statistics Research and Analysis as of November 19, 2019

Medtronic (MDT) Stock Competitor Research and Analysis

Boston Scientific Corporation (BSX)Johnson & Johnson (JNJ)
St. Jude Medical Inc. (STJ)Unitedhealth Group, Inc. (UNH)
WellPoint Inc. (WLP)Aetna Inc. (AET)

Mutual Funds with Medtronic (MDT) Stock in its top 10 holdings

FundCategoryMDT Holding Percentage
Thrivent Balanced Income Plus AAllocation--50% to 70% Equity0.63%
American Beacon Lg Cap Value InstLarge Value1.54%
American Century Capital Val ALarge Value2.3%
Advance Capital I Core Equity RetailLarge Blend2.44%
American Century Large Company Val BLarge Value2.21%
American Beacon Lg Cap Value ALarge Value1.54%
ALPS | WMC Research Value CLarge Value2.07%

ETFs with Medtronic (MDT) Stock in its top 10 holdings

Stock Research on Medtronic (MDT)

Latest Market News on Medtronic (MDT)


Click here to find the latest news on Medtronic (MDT)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Boston Scientific Corporation (BSX)
Johnson & Johnson (JNJ)
St. Jude Medical Inc. (STJ)
Unitedhealth Group, Inc. (UNH)
WellPoint Inc. (WLP)
Aetna Inc. (AET)